Back
Protagonist Therapeutics Stock Price Chart
Mode Mobile Could be Next in Line
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
54
PTGX
Protagonist Therapeutics
Last Price:
$46.29
Seasonality Move:
32.33%
7 Day Trial
ALL ACCESS PASS
$
7
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight selling pressure.
Protagonist Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.98 | Buy |
| 20-day SMA: | 46.68 | Sell |
| 50-day SMA: | 44.19 | Buy |
| 200-day SMA: | 41.99 | Buy |
| 8-day EMA: | 45.21 | Buy |
| 20-day EMA: | 45.78 | Buy |
| 50-day EMA: | 44.78 | Buy |
| 200-day EMA: | 40.5 | Buy |
Protagonist Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.36 | Sell |
| Relative Strength Index (14 RSI): | 51.08 | Buy |
| Chaikin Money Flow: | -53190 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.93 - 52.33) | Sell |
| Bollinger Bands (100): | (36.51 - 47.51) | Buy |
Protagonist Therapeutics Technical Analysis
| Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protagonist Therapeutics Stock
Is Protagonist Therapeutics Stock a Buy?
-
Protagonist Therapeutics share price is 46.28 while PTGX 8-day simple moving average is 43.98, which is a Buy signal.
-
The stock price of PTGX is 46.28 while Protagonist Therapeutics 20-day SMA is 46.68, which makes it a Sell.
-
Protagonist Therapeutics 50-day simple moving average is 44.19 while PTGX share price is 46.28, making it a Buy technically.
-
PTGX stock price is 46.28 and Protagonist Therapeutics 200-day simple moving average is 41.99, creating a Buy signal.
PTGX Technical Analysis vs Fundamental Analysis
Buy
54
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy or a Sell?
-
Protagonist Therapeutics stock is rated a BuyThe current Protagonist Therapeutics [PTGX] share price is $46.28. The Score for PTGX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
Protagonist Therapeutics Stock Info
Market Cap:
2.8B
Price in USD:
46.28
Share Volume:
517.4K
Protagonist Therapeutics 52-Week Range
52-Week High:
60.60
52-Week Low:
24.22
Buy
54
Protagonist Therapeutics (PTGX)
is a Buy
Protagonist Therapeutics Share Price Forecast
-
What is the Protagonist Therapeutics stock price today?The Protagonist Therapeutics stock price is 46.28 USD today.
-
Will PTGX stock go up or go down?Protagonist Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Protagonist Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protagonist Therapeutics is not overvalued.
Is Protagonist Therapeutics Stock a Buy?
-
Protagonist Therapeutics share price is 46.28 while PTGX 8-day exponential moving average is 45.21, which is a Buy signal.
-
The stock price of PTGX is 46.28 while Protagonist Therapeutics 20-day EMA is 45.78, which makes it a Buy.
-
Protagonist Therapeutics 50-day exponential moving average is 44.78 while PTGX share price is 46.28, making it a Buy technically.
-
PTGX stock price is 46.28 and Protagonist Therapeutics 200-day simple moving average is 40.50, creating a Buy signal.
Fundamental Analysis of Protagonist Therapeutics
Is Protagonist Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.08 per share, a decrease this year of $3.86 per share, and an increase next year of $0.16 per share.
Technical Analysis of Protagonist Therapeutics
Should I short Protagonist Therapeutics stock?
-
PTGX Moving Average Covergence Divergence (MACD) indicator is -0.36, suggesting Protagonist Therapeutics is a Sell
-
Protagonist Therapeutics Relative Strength Index (RSI) is 51.08, which suggest Protagonist Therapeutics is overbought
-
The Bollinger Bands (25) for Protagonist Therapeutics is (43.93 - 52.33), which suggest Protagonist Therapeutics is a Buy
-
The Bollinger Bands (100) for Protagonist Therapeutics is (36.51 - 47.51), which suggest Protagonist Therapeutics is a Buy
* Protagonist Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.